| Literature DB >> 27440997 |
Inayat Ullah1, Firoz Kabir2, Muhammad Iqbal1, Clare Brooks S Gottsch2, Muhammad Asif Naeem1, Muhammad Zaman Assir3, Shaheen N Khan1, Javed Akram3, Sheikh Riazuddin4, Radha Ayyagari5, J Fielding Hejtmancik6, S Amer Riazuddin2.
Abstract
PURPOSE: To identify pathogenic mutations responsible for autosomal recessive retinitis pigmentosa (arRP) in consanguineous familial cases.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27440997 PMCID: PMC4947966
Source DB: PubMed Journal: Mol Vis ISSN: 1090-0535 Impact factor: 2.367
Figure 1Pedigree drawings with haplotype formed from alleles of chromosome 6p microsatellite markers. A: PKRP259. B: PKRP268. C: PKRP301. D: PKRP309. E: PKRP356. F: PKRP364. G: PKRP367. The alleles forming the risk haplotype are shaded black, and the alleles that do not cosegregate with retinitis pigmentosa (RP) are shown in white. Squares = males; circles = females; filled symbols = affected individuals; double line between individuals = consanguineous marriage; diagonal line through a symbol = deceased family member.
Clinical characteristics of the patients screened for TULP1 mutations.
| PKRP259 | 10 | 28 | 6 | Night blindness | progressive | MD, Art. Atten, Pig.dep, PD | NAB, NF | NAB, NF | 6/36 | 6/40 |
| PKRP259 | 15 | 22 | 7 | Night blindness | progressive | MD, Art. Atten, Pig.dep, PD | NAB, NF | NAB, NF | 6/24 | 6/24 |
| PKRP268 | 12 | 17 | 7 | Night blindness | progressive | MD, Art. Atten, Pig.dep, PD | NAB, NF | NAB, NF | 6/20 | 6/20 |
| PKRP268 | 13 | 14 | 6 | Night blindness | progressive | MD, Art. Atten, Pig.dep, PD | NAB, NF | NAB, NF | 6/20 | 6/20 |
| PKRP301 | 14 | 20 | 5 | Night blindness | progressive | MD, Art. Atten, Pig.dep, PD | NAB, NF | NAB, NF | 6/18 | 6/20 |
| PKRP301 | 17 | 14 | 5 | Night blindness | progressive | MD, Art. Atten, Pig.dep, PD | NAB, NF | NAB, NF | 6/20 | 6/24 |
| PKRP309 | 11 | 34 | 6 | Night blindness | progressive | MD, Art. Atten, Pig.dep, PD | NAB, NF | NAB, NF | 6/30 | 6/28 |
| PKRP309 | 15 | 25 | 7 | Night blindness | progressive | MD, Art. Atten, Pig.dep, PD | NAB, NF | NAB, NF | 6/25 | 6/25 |
| PKRP356 | 10 | 10 | 5 | Night blindness | progressive | MD, Art. Atten, Pig.dep, PD | NAB, NF | NAB, NF | 6/12 | 6/12 |
| PKRP356 | 12 | 8 | 5 | Night blindness | progressive | MD, Art. Atten, Pig.dep, PD | NAB, NF | NAB, NF | 6/20 | 6/20 |
| PKRP364 | 10 | 58 | 7 | Night blindness | progressive | MD, Art. Atten, Pig.dep, PD | NAB, NF | NAB, NF | 6/50 | 6/50 |
| PKRP364 | 20 | 21 | 8 | Night blindness | progressive | MD, Art. Atten, Pig.dep, PD | NAB, NF | NAB, NF | 6/24 | 6/24 |
| PKRP367 | 11 | 31 | 6 | Night blindness | progressive | MD, Art. Atten, Pig.dep, PD | NAB, NF | NAB, NF | 6/24 | 6/28 |
| PKRP367 | 12 | 20 | 7 | Night blindness | progressive | MD, Art. Atten, Pig.dep, PD | NAB, NF | NAB, NF | 6/20 | 6/20 |
MD: macular degeneration; Art. Atten: artery attenuation; Pig.dep: pigment deposit; PD: Pale optic disc; NAB: no ‘a’ or ‘b’ wave response; NF: no flicker response; C-Age: current age; D-Age: age at first diagnosis of the retinal dystrophy.
Figure 2Fundus photographs of affected individuals illustrating symptoms of retinitis pigmentosa. A: OD and OS of individual 10 (affected: 30 years) of family PKRP259. B: OD and OS of individual 11 (affected: 18 years) of family PKRP309. C: OD and OS of individual 8 (unaffected: 52 years) of family PKRP259. Fundus photographs of affected individuals show bone spicule-like pigmentation in the mid-periphery of the retina, attenuated retinal arterioles, severe maculopathy, and disc pallor. OD = oculus dexter; OS = oculus sinister.
Figure 3Electroretinography responses of PKRP259 family members. In the stimulus conditions, scotopic 0 dB bright flashes elicit rod responses (left column of each pair), and a photopic 0 dB, 30 Hz flicker elicits cone responses (right column of each pair). Responses are of A) OD and B) OS of individual 10 (affected: 30 years); C) OD and D) OS of individual 14 (affected: 25 years); and E) OD and F) OS of individual 8 (unaffected: 52 years). The affected individuals exhibit undetectable electroretinography responses whereas the unaffected individual exhibits normal a- and b-waves suggestive of normal rod and cone function. OD = oculus dexter; OS = oculus sinister.
Two-point LOD scores of chromosome 6p markers for families A) PKRP259, B) PKRP268, C) PKRP301, D) PKRP309, E) PKRP356, F) PKRP364, and G) PKRP367.
| D6S439 | 48.26 | 35.18 | 2.21 | 2.16 | 1.95 | 1.74 | 1.68 | 1.15 | 0.65 | 2.21 | 0.00 |
| D6S1611 | 47.71 | 35.40 | 2.79 | 2.73 | 2.50 | 2.26 | 2.20 | 1.57 | 0.93 | 2.79 | 0.00 |
| D6S1645 | 48.26 | 35.61 | 2.02 | 1.97 | 1.77 | 1.57 | 1.51 | 1.00 | 0.51 | 2.02 | 0.00 |
Figure 4Sequence chromatograms of TULP1 variations identified in this study. A: Unaffected individual 8 is a heterozygous carrier, and affected individual 10 is homozygous for the single base pair substitution c.1561C>T in family PKRP259. B: Unaffected individual 19 is a heterozygous carrier, and affected individual 12 is homozygous for the splice region variant c.1495+4A>C in family PKRP268. C: Unaffected individual 12 is a heterozygous carrier, and affected individual 17 is homozygous for the single base pair substitution c.1466A>G in family PKRP301. D: Unaffected individual 7 is a heterozygous carrier, and affected individual 15 is homozygous for the single base pair substitution c.1466A>G in family PKRP309. E: Unaffected individual 8 is a heterozygous carrier, and affected individual 10 is homozygous for the single base pair substitution c.1466A>G in family PKRP356. F: Unaffected individual 18 is a heterozygous carrier, and affected individual 10 is homozygous for the two-base deletion c.286_287delGA in family PKRP364. G: Unaffected individual 9 is a heterozygous carrier, and affected individual 12 is homozygous for the single base pair substitution c.1466A>G in family PKRP367.
Figure 5Sequence conservation of amino acid Pro521 and nucleotide 1495+4A in TULP1 orthologs. Primates are green, placental mammals are blue, and vertebrates are purple. The arrow points to amino acid residue Pro521 and nucleotide 1495+4A, which were mutated in individuals with retinitis pigmentosa.
Figure 6In silico analysis of the splice donor site mutation in TULP1. The HSF3 algorithm predicted a consensus value (CV) of A) 82.12 for the wild-type (c.1495+4A) and B) 73.32 (c.1495+4C) for the mutant splice donor site. The CV deviation of −10.72 suggests that the loss of the wild-type splice site will result in the retention of intron 14 of TULP1, resulting in a frame shift likely to produce aberrant TULP1 (p.P499Rfs104*).
Single nucleotide polymorphism (SNP) haplotypes of affected individuals in PKRP301, PKRP309, PKRP356, and PKRP367 harboring the c.1466A>G (p.K489R) mutation in TULP1.
| Chr6: 35500039 | Chr6: 35500262 | Chr6: 35505901 | Chr6: 35506296 | Chr6: 35509796 | Chr6: 35511797 | ||
|---|---|---|---|---|---|---|---|
| 14 | G | C | T | G | T/C | C | |
| 15 | G | C | T | G | T/C | C | |
| 10 | G | C | T | G | T/C | C | |
| 12 | G | C | T | G | T/C | C |
List of mutations reported in TULP1-associated retinal dystrophies.
| Exon 1 | c.3G>A | p.M1I | arRP | 87 |
| Intron 2 | c.99+1G>A | Aberrant splicing | LCA, arRP | 88, 89 |
| Exon 4 | c.280G>T | p.D94Y | LCA | 90 |
| Intron 4 | c.350–2delAGA, (IVS4–2delAGA) | Aberrant splicing | arRP | 91 |
| Exon 5 | c.394_417del | p.E120_D127del | arRP | 92 |
| Exon 5 | c.539G>A | p.R180H | LCA | 93 |
| Exon 6 | c.627delC | p.S210QfsX27 | LCA | 94 |
| Exon 6 | c.629C>G | p.S210* | RP | 95 |
| Intron 7 | c.718+2T>C | Aberrant splicing | JRP, LCA | 96 |
| Exon 7 | c.725_728delCCAA | p.P242Qfs×16 | LCA | 97 |
| Exon 10 | c.901C>T | p.Q301* | LCA, RCD | 98, 99 |
| Exon 10 | c.937delC | p.Q301fs9* | arRP | 91 |
| Exon 10 | c.932G>A | p.R311Q | arRP | 100 |
| Exon 10 | c.956G>A | p.G319D | RP | 101 |
| Exon 10 | c.961T>G | p.Y321D | LCA | 97 |
| Intron 10 | c.999+5G>C | Aberrant splicing | JRP, LCA | 96 |
| Exon 11 | c.1025G>A | p.R342Q | arRP | 100 |
| Exon 11 | c.1047T>G | p.N349K | arRP | 102 |
| Exon 11 | c.1064A>T | p.D355V | LCA | 97 |
| Exon 11 | c.1087G>A | p.G363R | RCD | 103 |
| Exon 11 | c.1081C>T | p.R361* | LCA | 104 |
| Exon 11 | c.1102G>T | p.G368W | LCA | 89 |
| Intron 11 | c.1112+2T>C (IVS11 ds T-C +2) | Aberrant splicing | arRP | 105 |
| Intron 11 | c.1113–2A>C (IVS11 as A-C −2) | Aberrant splicing | LCA | 97 |
| Exon 12 | c.1138A>G | p.T380A | LCA, arRP | 83, 106, 107 |
| Exon 12 | c.1145T>C | p.F382S | arRP | 108 |
| Exon 12 | c.1198C>T | p.R400W | arRP, LCA, RD | 89, 109, 110 |
| Exon 12 | c.1199G>A | p.A400Q | arRP | 111 |
| Exon 12 | c.1204G>T | p.E402* | LCA | 89 |
| Intron 12 | c.1224+4A>G, (IVS12+4A>G) | Aberrant splicing | arRP | 92 |
| Exon 13 | c.1246C>T | p.R416C | ArRP | 87 |
| Exon 13 | c.1258C>A | p.R420S | RCD | 112 |
| Exon 13 | c.1259G>C | p.R420P | arRP | 88 |
| Exon 13 | c.1318C>T | p.R440* | LCA | 94 |
| Exon 14 | c.1349G>A | p.W450* | LCA | 90 |
| Exon 14 | c.1376T>A | p.I459K | arRP | 37, 88 |
| Exon 14 | c.1376T>C | p.I459T | arRP | 105 |
| Exon 14 | c.1376_1377delTA | p.I459Rfs×12 | LCA | 97 |
| Exon 14 | c.1381C>G | p.L461V | JRP, LCA | 96 |
| Exon 14 | c.1444C>T | p.R482W | arRP | 81, 109 |
| Exon 14 | c.1445G>A | p.A482Q | arRP | 107 |
| Exon 14 | c.1466A>G | p.K489R | arRP | 83, 92, 113 |
| Exon 14 | c.1472T>C | p.F491L | arRP | 88 |
| Intron 14 | c.1495+1G>A, (IVS14+1G>A) | Aberrant splicing | arRP | 37 |
| Intron 14 | c.1495+2_1495+3insT | Aberrant splicing | arRP | 114 |
| Intron 14 | c.1496–6C>A, (IVS14–6C>A) | Aberrant splicing | arRP | 88, 92 |
| Exon 15 | c.1511_1521delTGCAGTTCGGC | p.L504fs140* | arRP | 81 |
| Exon 15 | c.1518C>A | p.F506L | LCA | 94 |
| Exon 15 | c.1582_1587dupTTCGCC | p.F528_A529dup | LCA/arRP | 115 |
| Exon 15 | c.1604T>C | p.F535S | LCA | 116 |
arRP: autosomal recessive RP; RD: Retinal degeneration; LCA: Leber congenital amaurosis; JRP: Juvenile onset RP; RCD: Rod-Cone Dystrophy.